Post-approval studies (Phase 4)Study completedNCT01697787What this trial is testingAmodiaquine-Artesunate & Artemether-Lumefantrine Efficacy in Burkina FasoWho this might be right forMalaria Centre Muraz 150
Early research (Phase 1)Study completedNCT00320658What this trial is testingSafety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 AdjuvantWho this might be right forMalaria National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT03163121What this trial is testingSafety and Protective Efficacy of Genetically Attenuated PfSPZ-GA1 Vaccine in Healthy Dutch VolunteersWho this might be right forMalaria Sanaria Inc. 67
Large-scale testing (Phase 3)Study completedNCT00682578What this trial is testingA Comparative Study of Artekin With Standard Malarial Treatment Regimes in AfghanistanWho this might be right forUncomplicated Falciparum MalariaVivax Malaria University of Oxford 1,086
Not applicableWithdrawnNCT03394976What this trial is testingProspective Evaluation of an RDT to Screen for Gambiense HAT and Diagnose P. Falciparum MalariaWho this might be right forHuman African Trypanosomiasis Foundation for Innovative New Diagnostics, Switzerland
Testing effectiveness (Phase 2)Looking for participantsNCT07811908What this trial is testingPlatform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2)Who this might be right forUncomplicated Plasmodium Falciparum Malaria Novartis Pharmaceuticals 120
Not applicableStudy completedNCT00347113What this trial is testingSchistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-school Children in, TanzaniaWho this might be right forAnaemiaMalariaHepatosplenomegaly DBL -Institute for Health Research and Development 620
Large-scale testing (Phase 3)Study completedNCT03452475What this trial is testingComparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan ChildrenWho this might be right forPlasmodium Falciparum University of Oxford 219
Not applicableStudy completedNCT05052502What this trial is testingTargeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in ThailandWho this might be right forPlasmodium Falciparum MalariaPlasmodium Vivax Malaria University of California, San Francisco 14,977
Early research (Phase 1)Study completedNCT00344539What this trial is testingAMA1-C1/Alhydrogel + CpG 7909 for MalariaWho this might be right forPlasmodium Falciparum Malaria National Institute of Allergy and Infectious Diseases (NIAID) 75
Early research (Phase 1)Study completedNCT03882528What this trial is testingEvaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain NF54Who this might be right forMalaria,Falciparum U.S. Army Medical Research and Development Command 12
Post-approval studies (Phase 4)Study completedNCT06076213What this trial is testingTest Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the CongoWho this might be right forUncomplicated Plasmodium Falciparum Malaria Ministry of Public Health, Democratic Republic of the Congo 1,260
Not applicableStudy completedNCT01921413What this trial is testingClinical Performance Evaluation of Fyodor Urine Malaria Test (UMT)Who this might be right forMalaria Fyodor Biotechnologies Inc 1,893
Post-approval studies (Phase 4)Study completedNCT03453840What this trial is testingExtended Duration Artemether-lumefantrine Treatment for Malaria in ChildrenWho this might be right forUncomplicated Plasmodium Falciparum Malaria University of California, San Francisco 305
Post-approval studies (Phase 4)Study completedNCT01017770What this trial is testingArtemether-lumefantrine (AL) Versus Artesunate + Amodiaquine (ASAQ) for the Treatment of Uncomplicated Falciparum Malaria in Burkina FasoWho this might be right forUncomplicated P. Falciparum Malaria in Children Centre Muraz 340
Testing effectiveness (Phase 2)Study completedNCT01397227What this trial is testingAssess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge ModelWho this might be right forMalaria Crucell Holland BV 36
Testing effectiveness (Phase 2)Looking for participantsNCT07036159What this trial is testingAssess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 MonthsWho this might be right forMalaria GlaxoSmithKline 238
Post-approval studies (Phase 4)Looking for participantsNCT06068530What this trial is testingMass Vaccine and Drug Administration, BangladeshWho this might be right forPlasmodium Falciparum Malaria University of Oxford 10,000
Not applicableEnded earlyNCT01624337What this trial is testingMalaria Prevention CambodiaWho this might be right forMalaria Armed Forces Research Institute of Medical Sciences, Thailand 231
Testing effectiveness (Phase 2)Active Not RecruitingNCT07074665What this trial is testingDose Finding Trial of R21/Matrix-M in School ChildrenWho this might be right forMalaria (Plasmodium Falciparum) University of Oxford 40